Essa M. Saied | Genetics and Molecular Biology | Research Excellence Award

Assoc. Prof. Dr. Essa M. Saied | Genetics and Molecular Biology | Research Excellence Award

Associate Professor | Humboldt Universität zu Berlin | Germany

Dr. Essa M. Saied is a distinguished researcher at Suez Canal University, Egypt, specializing in medicinal chemistry, molecular pharmacology, and plant genetics. His work focuses on multi-target therapeutic strategies, anticancer drug design, and genetic and epigenetic mechanisms underlying crop resilience. Dr. Saied has authored numerous high-impact publications in leading journals, contributing significantly to advancements in both human health and agricultural sciences. His research integrates in vitro, in vivo, and in silico approaches, fostering innovative solutions for disease management and food security. With extensive collaborations across international research networks, he has advanced knowledge translation from laboratory discoveries to practical applications. His work has had a notable societal impact, particularly in promoting global health, sustainable agriculture, and biofortification strategies.

Citation Metrics (Scopus)

2239
1500
1000
500
0

Citations

2,239

Documents

72

h-index

31

Citations

Documents

h-index

View Google Scholar Profile
View Scopus Profile
View ORCID Profile

Featured Publications

Patrice X. Petit | Signal Transduction | Best Researcher Award

Dr. Patrice X. Petit | signal transduction | Best Researcher Award

 Research director | Centre National de la Recherche Scientifique | France

Dr. Patrice X. Petit, Doctor ès Sciences and PhD in Biology, is a Research Director at the French National Centre for Scientific Research (CNRS), where he has served since 1979 and established an internationally recognized career in cell biology. Trained at the Université Pierre et Marie Curie and the Université Denis Diderot (Paris), his work has focused on the molecular mechanisms governing cell death, mitochondrial dynamics, oxidative stress, and their implications in cancer biology, immunology, and toxicology. Over more than four decades, he has developed a broad international scientific presence through extensive teaching and research collaborations across Europe, North America, and Asia, including academic engagements with institutions such as the Chinese Academy of Sciences, Caltech, UT Southwestern, the Beatson Cancer Research Center in Glasgow, the University of Madrid, and multiple leading universities throughout Scandinavia, Germany, and France. His scientific leadership is further reflected in his service as an elected member (2016–2020) of the Scientific Council of the CNRS Institute of Biological Sciences (INSB). Dr. Petit has authored 134 scientific publications, accumulating approximately 12,500 citations and an h-index of 44, demonstrating sustained research influence across several biomedical domains, including contributions to plant biology. He is an active peer reviewer for major journals such as Cancer Research, Journal of Cell Biology, PNAS, Oncogene, and Cell Death and Differentiation, and he has served as a grant reviewer for major funding bodies, including the Austrian Academy of Sciences, the French National Research Agency (ANR), EMBO, the Swiss National Science Foundation, and the Fondation pour la Recherche Médicale. His interdisciplinary background—ranging from a formal qualification in history (Université Paris Diderot, 1979) to a DIU in rare diseases (Université de Strasbourg, 2017)—underscores both scientific depth and broader intellectual engagement. Through his sustained research output, international collaborations, and service to the scientific community, Patrice X. Petit has contributed significantly to advancing fundamental and translational knowledge in cell biology, with measurable societal impact across biomedical research and education.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., … Petit, P. X. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. The Journal of Experimental Medicine, 182(2), 367–377.

Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., … Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. The Journal of Experimental Medicine, 181(5), 1661–1672.

Kroemer, G., Petit, P., Zamzami, N., Vayssière, J. L., & Mignotte, B. (1995). The biochemistry of programmed cell death. The FASEB Journal, 9(13), 1277–1287.

Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. The Journal of Cell Biology, 130(1), 157–167.

Petit, P. X., Susin, S. A., Zamzami, N., Mignotte, B., & Kroemer, G. (1996). Mitochondria and programmed cell death: Back to the future. FEBS Letters, 396(1), 7–13.

Dr. Petit’s work has fundamentally advanced our understanding of mitochondrial biology and programmed cell death, shaping modern concepts of apoptosis, autophagy, and cellular stress responses. His discoveries enabled new biomedical approaches to cancer, immunology, and rare diseases

Xin Li | Sports Medicine | Best Researcher Award

Assoc. Prof. Dr. Xin Li | Sports Medicine | Best Researcher Award

Associate Professor| Tianjin Normal University | China

Dr. Xin Li is an accomplished scholar and educator specializing in clinical medicine and sports health sciences, currently serving as an Associate Professor at Tianjin Normal University since 2006. She obtained her Doctor of Medicine (MD) in Clinical Medicine from Tianjin Medical University in July 2006. Over nearly two decades of academic and research experience, Dr. Li has established herself as a leading expert at the intersection of clinical medicine, exercise science, and health management. Her teaching portfolio encompasses a range of courses in sports health, exercise rehabilitation, and health management, with a focus on integrating clinical case studies into theoretical instruction to enhance students’ practical competencies and professional insight. Dr. Li’s research primarily addresses exercise interventions for chronic diseases, sports injury prevention, and rehabilitation science, contributing to the growing evidence base linking physical activity with disease prevention and functional recovery. She has led and participated in numerous provincial and municipal research projects, achieving notable outcomes that have advanced the application of medical principles in sports health practice. To date, Dr. Li has published over ten academic papers in peer-reviewed core journals and international conferences, several of which have been widely cited and recognized within the academic community for their methodological rigor and clinical relevance. Her collaborative approach bridges disciplines such as physiology, public health, and kinesiology, fostering innovation and interdisciplinary integration in sports medicine research. Beyond academia, Dr. Li’s work holds significant societal impact, promoting the scientific development of exercise-based health strategies for chronic disease management and population well-being. Combining solid clinical expertise, pedagogical excellence, and a strong research record, Dr. Xin Li continues to contribute meaningfully to the advancement of sports health education and evidence-based medical practice in China and beyond.

Profile: Scopus 

Featured Publications

Li, X. (2025). The influence of initial and final character positional probabilities on the flexibility of position coding in two-character word identification. Acta Psychologica Sinica.

Dr. Xin Li’s work bridges clinical medicine and sports science, advancing evidence-based approaches to exercise intervention, chronic disease prevention, and rehabilitation. Her research and teaching contribute to improving public health outcomes and enhancing human performance, promoting global innovation in integrated medical and sports health education.

Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Directors of Department in Hospital| Tongji University | China

Dr. Shaoqing Yu, PhD, is the Director of the Departments of Otorhinolaryngology–Head and Neck Surgery and Allergy at Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. An accomplished clinician-scientist, Dr. Yu specializes in allergy, immunology, and otorhinolaryngology, with a research focus on the mechanisms and clinical management of allergic rhinitis and upper airway inflammation. He has led or participated in more than 20 major research projects, including those funded by the National Natural Science Foundation of China, and has published over 70 peer-reviewed papers in high-impact international journals such as JAMA, Allergy, Clinical and Experimental Allergy, and Clinical Reviews in Allergy & Immunology. His work has substantially advanced understanding of immune regulation and translational therapies in allergic diseases. Dr. Yu is an active member of the European Academy of Allergy and Clinical Immunology (EAACI) and the Chinese Society of Otolaryngology in Traditional Chinese and Western Medicine, fostering global and interdisciplinary collaborations. His achievements have been recognized through numerous awards, including the Third Prize of the Shanghai Medical Technology Award, the Third Prize of the Military Medical Achievement Award, and the Tongji University Taihe Medical Education Award. With over 20 patents to his name and selection for the prestigious Shanghai Oriental Talent Plan, Dr. Yu continues to contribute significantly to medical innovation, education, and the improvement of public health outcomes in China and internationally.

Profiles: Scopus | ORCID 

Featured Publications

Yu, S., et al. (2025). An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: The DUBHE randomized clinical trial. Nature Communications.

Yu, S., et al. (2025). Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis. International Immunopharmacology.

Yu, S., et al. (2025). Xylulose 5-phosphate fosters sustained antitumor activity of progenitor-like exhausted SLC35E2⁺ CD8⁺ T effector cells. Cell Metabolism.

Yu, S., et al. (2025). Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment. Translational Andrology and Urology.

Yu, S., et al. (2025). Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways. Translational Andrology and Urology.

Dr. Shaoqing Yu’s pioneering research in allergy and immunology has advanced understanding of airway inflammatory diseases and driven the development of innovative diagnostic and therapeutic strategies. His work bridges basic science and clinical application, improving patient outcomes and shaping global standards in allergic disease management.

Andrea Suranyi | Obstetrics | Best Researcher Award

Dr. Andrea Suranyi | Obstetrics | Best Researcher Award

Associated Professor| University of Szeged | Hungary

Dr. Andrea Suranyi is a researcher at the University of Szeged (Szegedi Tudományegyetem, SZTE), Hungary, whose scholarly work reflects a strong and consistent contribution to her field at both national and international levels. She has authored 67 scientific publications, including 62 peer-reviewed journal articles, one book chapter, and four conference papers, with the majority—40 papers—published in internationally recognized foreign journals. Her research has garnered 339 citations, of which 271 are independent, and she maintains a Hirsch index of 10 (11 total), evidencing the influence and sustainability of her academic impact. Beyond her core research output, Dr. Surányi has produced 137 abstracts, 72 additional scientific works, and several educational and outreach-oriented publications, demonstrating her active engagement in both specialized and public scientific communication. She has also contributed to higher education through two Hungarian-language university textbooks and four educational materials, emphasizing her dedication to knowledge transfer and academic mentorship. Her work spans multiple disciplines, with a focus on fostering collaboration, advancing research visibility, and strengthening connections between Hungarian and international scientific communities. Through her sustained publication record, interdisciplinary approach, and commitment to education, Dr. Surányi has established herself as a respected scholar whose research and teaching continue to shape and inspire scientific inquiry and intellectual development in Hungary and beyond.

Featured Publications

Koreck, A., Surányi, A., Szöny, B. J., Farkas, A., Bata-Csörgő, Z., & Kemény, L. (2002). CD3⁺CD56⁺ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clinical & Experimental Immunology, 127(1), 176–182. Cited by 98

Bede, O., Surányi, A., Pintér, K., Szlávik, M., & Gyurkovits, K. (2003). Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: A randomized, placebo-controlled, double-blind study. Magnesium Research, 16(4), 262–270. Cited by 51

Bede, O., Nagy, D., Surányi, A., Horváth, I., Szlávik, M., & Gyurkovits, K. (2008). Effects of magnesium supplementation on the glutathione redox system in atopic asthmatic children. Inflammation Research, 57(6), 279–286. Cited by 50

Surányi, A., Kozinszky, Z., Molnár, A., Nyári, T., Bitó, T., & Pál, A. (2013). Placental three-dimensional power Doppler indices in mid-pregnancy and late pregnancy complicated by gestational diabetes mellitus. Prenatal Diagnosis, 33(10), 952–958. Cited by 37

Jakó, M., Surányi, A., Kaizer, L., Németh, G., & Bártfai, G. (2019). Maternal hematological parameters and placental and umbilical cord histopathology in intrauterine growth restriction. Medical Principles and Practice, 28(2), 101–108. Cited by 32

Dr. Andrea Surányi’s research advances understanding of immunological, metabolic, and perinatal health processes, bridging clinical science with practical healthcare outcomes. Her work contributes to improved diagnostic and therapeutic approaches in dermatology, pediatrics, and obstetrics, fostering evidence-based innovation and enhancing maternal and child health on a global scale.

Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Dr. Nermin Mutlu Bilgic | Gastroenterology | Best Researcher Award

Specialist | University of health sciences | Turkey

Dr. Nermin Mutlu Bilgic is a Gastroenterology Specialist at the University of Health Sciences Ümraniye Training and Research Hospital in Istanbul, Türkiye. She earned her Doctor of Medicine degree from Istanbul University Cerrahpaşa Faculty of Medicine in 2004, completed her residency in Internal Medicine at Maltepe University between 2007 and 2012, and obtained her subspecialty in Gastroenterology at Ümraniye Training and Research Hospital from 2015 to 2019. With over fifteen years of academic and clinical experience, Dr. Bilgiç specializes in hepatology, metabolic liver diseases, and inflammatory gastrointestinal disorders. She has served as Principal Investigator for international multicenter clinical trials evaluating the efficacy and safety of Saroglitazar Magnesium in patients with Primary Biliary Cholangitis and Nonalcoholic Steatohepatitis, reflecting her active contribution to global research in liver diseases. She has received certified training in Good Clinical Practice (GCP) from Roche/Genentech and the Global Health Training Centre, ensuring compliance with international ethical and regulatory standards. Dr. Bilgiç has authored and co-authored peer-reviewed publications and presented her work at several national and international gastroenterology and internal medicine conferences. Her professional focus integrates patient-centered clinical care with translational research aimed at improving therapeutic outcomes and understanding the mechanisms of chronic liver disease. She is also actively engaged in mentoring residents and fellows, contributing to medical education and the advancement of clinical research culture within her institution. Through her leadership in clinical trials, scientific collaborations, and commitment to ethical medical practice, Dr. Nermin Mutlu Bilgiç continues to make a meaningful impact on the advancement of gastroenterology and hepatology in both national and international contexts.

Profiles: Google Scholar | ORCID

Featured Publications

Kul, S., Caliskan, Z., Guvenc, T. S., Celik, F. B., Sarmis, A., Atici, A., Konal, O., Akıl, M., & Bilgiç, N. M. (2023). Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with …. Microvascular Research, 146, 104458 Cited by 31

Sayar, S., Aykut, H., Kaya, Ö., Kürbüz, K., Ak, Ç., Gökçen, P., Bilgiç, N. M., Adalı, G., & others. (2021). Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with celiac disease. The Turkish Journal of Gastroenterology, 32(7), 600–606 Cited by 13

Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Bilgiç, N. M., & others. (2020). Risk of hepatitis B reactivation during anti-TNF therapy: Evaluation of patients with past hepatitis B infection. The Turkish Journal of Gastroenterology, 31(7), 522–528 Cited by 13

Ozdil, K., Ozturk, O., Çalık, E. S., Akbas, E. S., Kanat, E., Caliskan, Z., Demirdag, H., Bilgiç, N. M., & others. (2016). Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. Northern Clinics of Istanbul, 3(1), 46–50 Cited by 11

Adali, G., Bilgiç, N. M., Kalaman, A. E., Ozturk, O., & Ozdil, K. (2023). Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study. Hepatology Forum, 4(3), 129–135 Cited by 8

 

Dr. Nermin Mutlu Bilgic work advances the understanding and management of chronic liver and metabolic diseases through evidence-based clinical research and international collaboration. Her contributions to hepatology and gastroenterology foster improved patient outcomes, support ethical research practices, and drive innovation in global liver health.

Aylin Köseler | Medicine | Best Researcher Award

Prof. Dr. Aylin Köseler | Medicine | Best Researcher Award

Professor | Pamukkale University Medical Faculty | Turkey

Professor Aylin Köseler is a distinguished academic in the field of biophysics and molecular genetics, currently serving in the Department of Biophysics at Pamukkale University Faculty of Medicine. Her extensive research career spans over two decades, focusing on the molecular mechanisms underlying genetic variability, pharmacogenomics, and disease susceptibility. She has made significant contributions to understanding gene–environment interactions, genetic polymorphisms, and epigenetic regulations associated with cardiovascular diseases, metabolic disorders, and infectious diseases such as COVID-19. Prof. Köseler has led and participated in numerous national and international research projects, including collaborations with prestigious institutions such as Harvard Medical School and the University of California, Los Angeles (UCLA). Her notable involvement in projects like Whole Genome Sequencing of Ancient DNA and Epigenetics in Identical Twins and COVID-19 Patients demonstrates her commitment to interdisciplinary science bridging genetics, biophysics, and clinical medicine. Throughout her academic tenure, she has supervised graduate research and contributed to advancing biomedical science through experimental and computational biophysics approaches. She has authored and co-authored numerous peer-reviewed publications and presented her work at scientific conferences worldwide. Her research outputs have been recognized for their scientific rigor and impact on personalized medicine, population genetics, and evolutionary biology. Beyond academic excellence, Prof. Köseler’s work has substantial societal implications, particularly in improving diagnostic precision, therapeutic efficacy, and public health outcomes. Her dedication to fostering young researchers and promoting collaborative innovation underscores her leadership in the Turkish and international scientific communities. Her ongoing projects continue to explore genetic determinants of complex diseases and epigenetic modulation, contributing valuable insights to the global biomedical research landscape.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Sabirli, R., Köseler, A., Goren, T., Turkcuer, I., & Kurt, O. (2021). High GRP78 levels in COVID-19 infection: A case-control study. Life Sciences, 265, 118781. https://doi.org/10.1016/j.lfs.2020.118781 — Cited by: 128

  2. Palmeira, A., Sousa, E., Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., Kurt, Ö., et al. (2020). Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection. Pharmaceuticals, 13(6), 132. https://doi.org/10.3390/ph13060132 — Cited by: 77

  3. Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., & Kurt, Ö. (2020). Endoplasmic reticulum stress markers in SARS-CoV-2 infection and pneumonia: Case-control study. In Vivo, 34(3 Suppl), 1645–1650. https://doi.org/10.21873/invivo.11938 — Cited by: 75

  4. Akca, H., Demiray, A., Yaren, A., Bir, F., Koseler, A., Iwakawa, R., Bagci, G., et al. (2013). Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer. Cancer Genetics, 206(3), 73–80. https://doi.org/10.1016/j.cancergen.2013.05.012 — Cited by: 58

  5. Atalay, E. Ö., Koyuncu, H., Turgut, B., Atalay, A., Yildiz, S., Bahadir, A., & Köseler, A. (2005). High incidence of Hb D-Los Angeles [β121 (GH4) Glu→ Gln] in Denizli Province, Aegean region of Turkey. Hemoglobin, 29(4), 307–310. https://doi.org/10.1080/03630260500217438 — Cited by: 50

Adem Güner | Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. Adem Güner | Molecular Biology | Best Researcher Award

Corresponding Author at Sinop University, Turkey

Assoc. Prof. Dr. Adem Güner is an accomplished academic specializing in biology, toxicology, cancer research, and occupational health & safety. His career reflects a strong interdisciplinary approach, integrating fundamental biological sciences with applied health innovations. He has contributed extensively to scientific research through publications in high-impact journals, covering cancer biology, nanoparticle synthesis, apoptosis mechanisms, and environmental toxicology. Early in his career, Dr. Güner explored the biological activities of marine algae and lichens, highlighting their cytotoxic, antioxidant, and protective roles. More recently, he has advanced into occupational safety research, incorporating modern tools such as virtual reality-based risk assessment and accident process management. Beyond publications, he has demonstrated leadership through departmental responsibilities, supervision of students, and participation in nationally funded projects. His active involvement in professional organizations such as EACR and MOKAD, alongside community-impact projects, further illustrates his commitment to advancing both academic knowledge and societal well-being at local and international levels.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Assoc. Prof. Dr. Adem Güner holds a strong academic background with progressive degrees in biology. He earned his Master’s degree in General Biology from Atatürk University, where he laid the foundation for his interest in cellular biology and toxicology. He then pursued doctoral research at Ege University, obtaining his Ph.D. in General Biology. During his doctoral studies, he focused on exploring the cytotoxic, antioxidant, and genoprotective properties of marine algae and lichens, producing work that connected natural product research with cancer biology. His academic training was not limited to laboratory work but also extended into applied aspects of occupational health, environmental biology, and molecular research. This educational journey has enabled him to develop expertise in both experimental biology and applied health sciences. The combination of fundamental biological studies and applied technological solutions reflects his broad perspective on using education as a bridge between science and practice.

Experience

Assoc. Prof. Dr. Güner has accumulated over a decade of academic and research experience across respected Turkish universities. He began his career as a Research Assistant at Giresun University, where he gained foundational experience in teaching, laboratory management, and collaborative research. Later, he joined Sinop University’s Faculty of Health Sciences, where he progressed through the roles of Assistant Professor and now Associate Professor. In these roles, he has conducted impactful studies in cancer research, toxicology, nanoparticle applications, and occupational safety. His involvement as a project leader and researcher in nationally funded programs, including those supported by TÜBİTAK, has strengthened his expertise in grant management and interdisciplinary teamwork. As Vice Chair of his department, he has contributed to academic governance and curriculum development. Dr. Güner’s experience also extends internationally, with memberships in leading associations such as EACR and MOKAD, which have enabled him to remain connected with global scientific advancements and collaborations.

Research Interest

Assoc. Prof. Dr. Adem Güner’s research interests span multiple disciplines, reflecting his interdisciplinary expertise. In the field of cancer biology, he investigates cytotoxicity, apoptosis, and molecular mechanisms of natural and synthetic compounds, focusing on their potential as anticancer agents. His early studies on marine algae and lichens emphasized their antioxidant and protective activities against genotoxic and oxidative stress. He also explores the role of nanoparticle synthesis in biomedical applications, especially for drug delivery and therapeutic purposes. Beyond cancer research, Dr. Güner has a strong interest in environmental toxicology, studying the effects of pollutants and chemicals on human health. More recently, his focus has expanded into occupational health and safety, where he applies innovative technologies such as virtual reality-based risk assessment and accident process modeling to prevent workplace hazards. This diverse range of interests highlights his dedication to combining fundamental biology with real-world applications, ultimately advancing both scientific understanding and societal health.

Award and Honor

Throughout his career, Dr. Adem Güner has earned recognition for his academic and research contributions in biology, toxicology, and health sciences. His research excellence has been acknowledged through nationally funded grants and projects, including support from TÜBİTAK, which underscores his ability to secure competitive funding and lead impactful investigations. As a dedicated academic, he has supervised student theses and guided young researchers, further enhancing his professional standing. His leadership roles, such as serving as Vice Chair of his department, demonstrate institutional recognition of his organizational and academic capabilities. Dr. Güner’s membership in esteemed international organizations such as The European Association for Cancer Research (EACR) and Molecular Cancer Research Association (MOKAD) reflects peer recognition of his scientific contributions and his integration into the global research community. These honors and affiliations collectively highlight his academic impact, leadership potential, and ongoing commitment to advancing research with both scientific and societal benefits.

Research Skills

Assoc. Prof. Dr. Adem Güner possesses a versatile set of research skills that combine experimental, analytical, and applied methodologies. He is proficient in cell culture techniques, cytotoxicity assays, and apoptosis analysis, enabling him to evaluate anticancer activities of natural and synthetic compounds. His expertise extends to nanoparticle synthesis and characterization, particularly in biomedical applications, and he has conducted detailed investigations in environmental toxicology, examining pollutant impacts on health. Dr. Güner also demonstrates strong skills in molecular biology techniques, including oxidative stress analysis and genotoxicity evaluation. Beyond laboratory expertise, he is adept in project management and grant acquisition, having led and contributed to multiple TÜBİTAK-funded projects. In recent years, he has developed applied research skills in virtual reality-based occupational risk assessment and accident prevention modeling, showcasing his adaptability in adopting modern technologies. His comprehensive skill set reflects not only technical proficiency but also an ability to integrate science into innovative health and safety applications.

Publication Top Notes

Title: Novel benzimidazole derivatives: Synthesis, in vitro cytotoxicity, apoptosis and cell cycle studies
Authors: H. Atmaca, S. İlhan, M.B. Batır, Ç.Ç. Pulat, A. Güner, H. Bektaş
Year: 2020
Citation: 51

Title: Multi-Biomarker Responses After Exposure to Pollution in the Mediterranean Mussels (Mytilus galloprovincialis L.) in the Aegean Coast of Turkey
Authors: D. Ozkan, M. Dagdeviren, S. Katalay, A. Guner, N.Ü.K. Yavaşoğlu
Year: 2017
Citation: 39

Title: Antimicrobial and antioxidant activities with acute toxicity, cytotoxicity and mutagenicity of Cystoseira compressa (Esper) Gerloff & Nizamuddin from the coast of Urla
Authors: A. Güner, C. Köksal, Ş.B. Erel, H. Kayalar, A. Nalbantsoy, A. Sukatar, …
Year: 2015
Citation: 38

Title: Apoptosis-inducing activities of Halopteris scoparia L. Sauvageau (Brown algae) on cancer cells and its biosafety and antioxidant properties
Authors: A. Güner, A. Nalbantsoy, A. Sukatar, N.Ü. Karabay Yavaşoğlu
Year: 2019
Citation: 35

Title: Histopathological and apoptotic changes on marine mussels Mytilus galloprovincialis (Lamark, 1819) following exposure to environmental pollutants
Authors: A. Yavaşoğlu, D. Özkan, A. Güner, S. Katalay, F. Oltulu, N.Ü.K. Yavaşoğlu
Year: 2016
Citation: 32

Title: Anticancer and antiangiogenesis activities of novel synthesized 2-substituted benzimidazoles molecules
Authors: A. Güner, E. Polatli, T. Akkan, H. Bektaş, C. Albay
Year: 2019
Citation: 20

Title: Ameliorative effect of edible Halopteris scoparia against cadmium‐induced reproductive toxicity in male mice: A biochemical and histopathologic study
Authors: Ö. Güner, A. Güner, A. Yavaşoğlu, N.Ü. Karabay Yavaşoğlu, O. Kavlak
Year: 2020
Citation: 16

Title: The cytogenetic effects of the aqueous extracts of migratory locust (Locusta migratoria L.) in vitro
Authors: H. Turkez, Ü. İncekara, A. Güner, E. Aydın, E. Dirican, B. Togar
Year: 2014
Citation: 16

Title: Apoptosis-inducing activity of safflower (Carthamus tinctorius L.) seed oil in lung, colorectal and cervix cancer cells
Authors: A. Güner, S. Kızılşahin, A. Nalbantsoy, N.Ü. Karabay Yavaşoğlu
Year: 2020
Citation: 15

Conclusion

In conclusion, Assoc. Prof. Dr. Adem Güner is highly suitable for the Best Researcher Award. His extensive contributions in cancer biology, toxicology, and occupational safety research—supported by impactful publications, funded projects, and academic mentorship—demonstrate a career dedicated to advancing both scientific knowledge and societal well-being. With his proven ability to integrate basic science with applied health technologies, he not only enriches the academic community but also addresses real-world challenges in health and safety. His future potential for leadership in international collaborations and innovative research makes him a deserving candidate for this award.

Kausik Paul | Immunology and Microbiology | Best Researcher Award

Dr . Kausik Paul | Immunology and Microbiology | Best Researcher Award

Project Scientist at Cedars-Sinai Medical Center , United States

Dr. Kausik Paul is a dedicated immunologist and project scientist at Cedars-Sinai Medical Center, specializing in red blood cell (RBC) alloimmunization and transfusion medicine. With a strong academic foundation in microbiology, biophysics, and immunology, he has contributed significantly to understanding immune responses in lupus and transfusion settings. His work includes notable first-author publications in Frontiers in Immunology and Antioxidants, as well as multiple conference presentations on alloantibody responses in lupus mouse models. Dr. Paul has a strong history of scientific productivity, including peer-reviewed publications, patents, and impactful collaborative research. His technical expertise spans flow cytometry, cytokine profiling, and qPCR, supporting his efforts to refine personalized transfusion protocols. While he could further enhance his profile by securing independent funding and leading larger-scale projects, his current contributions reflect originality, depth, and clinical relevance. Dr. Paul is a highly suitable candidate for the Best Researcher Award, with clear potential for continued impactful research.

Professional Profile 

Education🎓

Dr. Kausik Paul has a comprehensive and interdisciplinary educational background that has shaped his expertise in immunology and transfusion medicine. He began his academic journey with a Bachelor of Science in Microbiology, followed by a Master’s degree in Biophysics from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad. His growing interest in immune mechanisms led him to pursue a Ph.D. in Infectious Diseases and Immunology at IICB-CSIR and Jadavpur University, Kolkata, where he developed a strong foundation in antigen-antibody interactions and immune response regulation. To further expand his knowledge, Dr. Paul completed postdoctoral training in immunology at the University of Manitoba and the University of Arizona, gaining exposure to advanced immunological techniques and research models. His education has been integral to his development as a researcher, equipping him with the scientific rigor and technical skills necessary to investigate complex immune responses, particularly in the context of RBC alloimmunization and autoimmune conditions like lupus.

Professional Experience📝

Dr. Kausik Paul has amassed extensive professional experience in immunology, with a focus on transfusion medicine and red blood cell (RBC) alloimmunization. Currently serving as a Project Scientist at Cedars-Sinai Medical Center since 2022, he leads research exploring immune responses to RBC antigens, particularly in lupus models. Prior to this, he held faculty positions as an Assistant Professor at Seacom Skills University and Glocal University, where he was involved in both teaching and research. His earlier postdoctoral appointments at the University of Manitoba and the University of Arizona enriched his expertise in cellular immunology and advanced laboratory techniques. Throughout his career, Dr. Paul has demonstrated a strong command of experimental approaches such as flow cytometry, cytokine profiling, and qPCR. His roles have included both independent and collaborative research, manuscript writing, and conference presentations. These experiences have collectively positioned him as a skilled and impactful researcher in the field of immunological science.

Research Interest🔎

Dr. Kausik Paul’s research interests lie primarily in immunology, with a specialized focus on red blood cell (RBC) alloimmunization, autoimmune disorders, and transfusion medicine. He is particularly interested in understanding the molecular and cellular mechanisms behind alloantibody formation in response to RBC antigens, especially in autoimmune conditions such as lupus. His current research explores the roles of type 1 and type 2 interferons in modulating immune responses to transfused RBCs, aiming to develop personalized transfusion strategies that minimize alloimmunization risk. Dr. Paul is also deeply invested in investigating inflammatory cytokine profiles, interferon-stimulated gene expression, and antigen presentation processes. His long-term goal is to translate basic immunological findings into clinically applicable solutions that enhance patient outcomes during blood transfusion therapies. Through the integration of advanced immunological techniques and animal models, Dr. Paul aspires to contribute significantly to the field of transfusion science and improve therapeutic protocols for immunocompromised

Award and Honor🏆

Dr. Kausik Paul has been recognized with several prestigious awards and honors throughout his academic and research career, reflecting his dedication and contributions to the field of immunology. He was the recipient of the Senior Research Fellowship (SRF) from the Council of Scientific and Industrial Research (CSIR), India, in 2007, which is awarded to outstanding doctoral candidates in scientific research. In 2006, he was also granted a Senior Research Fellowship through a project funded by the Department of Biotechnology (DBT), India, underscoring his involvement in high-impact research initiatives. Earlier, in 2003, Dr. Paul received a Research Fellowship under a project funded by the Department of Science and Technology (DST), India, during the initial stages of his research career. These honors not only highlight his scientific capabilities but also demonstrate the recognition he has earned from national funding agencies for his commitment to advancing biomedical research and innovation in immunology and related fields.

Research Skill🔬

Dr. Kausik Paul possesses a comprehensive range of research skills that span basic and translational immunology, with a strong emphasis on red blood cell (RBC) alloimmunization and autoimmune disease models. He is highly proficient in advanced laboratory techniques, including flow cytometry for cellular analysis and crossmatching, quantitative PCR for gene expression profiling, and ELISA-based assays for measuring cytokines and immune responses. His expertise extends to in vivo experimental design using mouse models, particularly in lupus research, where he investigates type 1 and type 2 interferon pathways and their influence on alloantibody production. Dr. Paul also demonstrates strong analytical skills in data interpretation, experimental troubleshooting, and scientific writing, as evidenced by his numerous publications and conference presentations. His ability to integrate immunological theory with practical experimentation has been instrumental in uncovering novel insights into transfusion medicine. Collectively, his technical competencies and critical thinking make him a valuable contributor to biomedical research.

Conclusion💡

Dr. Kausik Paul demonstrates a strong case for the Best Researcher Award, especially within the domains of transfusion medicine and immunology. He has a proven track record of impactful research, interdisciplinary collaboration, innovation (patents), and consistent engagement with the global scientific community through publications and conferences.

While there are areas he can build on—especially independent funding, mentorship, and institutional leadership—his current trajectory and recent accomplishments, particularly in a high-impact field like lupus-related RBC alloimmunization, are highly commendable.

Publications Top Noted✍

  • Title: Activated T lymphocytes migrate toward the cathode of DC electric fields in microfluidic devices
    Authors: J Li, S Nandagopal, D Wu, SF Romanuik, K Paul, DJ Thomson, F Lin
    Year: 2011
    Citations: 91

  • Title: N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl⁺ cells by endothelial nitric oxide synthase-mediated production of nitric oxide
    Authors: S Rakshit, J Bagchi, L Mandal, K Paul, D Ganguly, S Bhattacharjee, …
    Year: 2009
    Citations: 48

  • Title: Leishmania donovani Infection of Human Myeloid Dendritic Cells Leads to a Th1 Response in CD4⁺ T Cells from Healthy Donors and Patients with Kala-Azar
    Authors: M Ghosh, L Mandal, S Maitra, S Rakshit, K Paul, J Bagchi, D Ganguly, …
    Year: 2006
    Citations: 30

  • Title: Granulocyte–macrophage colony‐stimulating factor drives monocytes to CD14^low CD83⁺ DCSIGN⁻ interleukin‐10‐producing myeloid cells with differential …
    Authors: D Ganguly, K Paul, J Bagchi, S Rakshit, L Mandal, G Bandyopadhyay, …
    Year: 2007
    Citations: 26

  • Title: Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis
    Authors: S Mallick, S Halder, A Dutta, S Dey, K Paul, S Maiti, C Bandyopadhyay, …
    Year: 2013
    Citations: 22

  • Title: Dendritic cells and antigen trapping technology—a revolution in vaccine/immunotherapy strategy
    Authors: C Pal, D Ganguly, K Paul, S Pal
    Year: 2007
    Citations: 5

  • Title: Distinct RBC alloantibody responses in type 1 interferon-dependent and -independent lupus mouse models
    Authors: K Paul, R Hernández-Armengol, JY Lee, CY Chang, T Shibata, …
    Year: 2024
    Citations: 3

  • Title: Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO)
    Authors: S Bandyopadhyay, BC Pal, J Parasuraman, S Roy, JB Chakrabotry, …
    Year: 2016
    Citations: 1

  • Title: Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent …
    Authors: JB Chakraborty, SK Mahato, K Joshi, V Shinde, S Rakshit, N Biswas, …
    Year: 2012
    Citations: 1

Sándor Bordács | Agricultural and Biological Sciences | Best Researcher Award

Assist. Prof. Dr. Sándor Bordács | Agricultural and Biological Sciences | Best Researcher Award

university teacher at  Hungarian University of Agriculture and Life Sciences , Hungary

Sándor Bordács is a highly experienced forestry expert with over 30 years of dedicated work in forest genetics and reproductive material. His career spans research, policy development, and academic roles, including his current position as Assistant Professor at the Hungarian University of Agriculture and Life Sciences. He has led multiple national departments and represented Hungary in key international forestry bodies such as EUFORGEN, OECD, and the European Commission. His strengths lie in policy influence, technical training, and international collaboration. While his contributions to applied forestry and regulation are substantial, his profile would benefit from a clearer record of scientific publications and recent academic research outputs. Fluent in English and German, with strong leadership and communication skills, he has contributed significantly to the development and harmonization of forest reproductive material regulations in Europe. He is a strong candidate for a Best Researcher Award, especially if the focus includes long-term applied research and policy impact.

Professional Profile 

Education🎓

Sándor Bordács has a solid educational background rooted in forestry and forest genetics. He earned his degree in Forestry Engineering from the University of Sopron, Hungary, in 1987, followed by postgraduate Ph.D. training in forest genetics supported by the Hungarian Academy of Sciences. He was later awarded a Ph.D. in forest genetics and forestry breeding from the same university in 2004. His academic journey includes multiple international fellowships and training programs focused on molecular genetics and renewable energy, notably in Austria and Germany. He completed postdoctoral fellowships at the Austrian Research Centre Seibersdorf, supported by both the Ministry for Scientific and Research and the Austrian-Hungarian Action Foundation. He also participated in several short courses and study trips across Europe, enhancing his expertise in forest reproductive materials, biomass use, and EU forest legislation. His education reflects a deep commitment to advancing forest science through both theoretical knowledge and practical international exposure.

Professional Experience📝

Sándor Bordács has amassed over three decades of professional experience in forestry, with a specialized focus on forest reproductive material (FRM) and forest genetics. Beginning his career as a research assistant at the University of Sopron, he went on to serve in various national forestry institutions in Hungary, including the National Institute for Agricultural Quality Control and the National Food Chain Safety Office. He held multiple leadership positions, notably as Head of Department for Forest and Biomass Reproductive Material from 2005 to 2019. Since 2019, he has been serving as an Assistant Professor at the Hungarian University of Agriculture and Life Sciences. His work combines scientific, regulatory, and training roles, with extensive contributions to drafting national and EU-level forestry regulations. He also represented Hungary in key international forestry committees such as EUFORGEN and the OECD. His professional journey reflects a blend of technical expertise, leadership, and significant policy influence in forestry.

Research Interest🔎

Sándor Bordács’s research interests lie primarily in the fields of forest genetics, forest reproductive material (FRM), and forest genetic resources (FGR). He focuses on the genetic improvement, conservation, and sustainable use of forest species, with an emphasis on ensuring the adaptability and resilience of forests under changing environmental conditions. His work explores the certification, regulation, and traceability of FRM within the European Union, aligning national practices with EU and OECD standards. He has a strong interest in molecular genetics as applied to forestry, gained through international fellowships and collaborations. Additionally, he is engaged in studying the use of genetically diverse planting material for climate-resilient forestry and biomass production. His research also includes the integration of policy, science, and practice to improve forest biodiversity and productivity. Through international cooperation, database development, and stakeholder training, he contributes to the long-term conservation and sustainable management of forest genetic resources at both national and European levels.

Award and Honor🏆

While specific awards and honors are not explicitly listed in the available information, Sándor Bordács’s distinguished career reflects significant professional recognition through his roles and responsibilities. He has been repeatedly entrusted with national leadership positions, including Head of Department roles in key Hungarian forestry institutions over a span of nearly two decades. His appointment as Hungary’s national representative to prominent international bodies such as EUFORGEN, the OECD Forest Seed Scheme, and the European Commission’s Forestry Working Group highlights his respected standing in the field of forest genetics and reproductive material. Furthermore, his selection as a trainer for the European Union’s TAIEX programs demonstrates trust in his expertise at the international level. These roles are indicative of his strong professional reputation and the high regard in which he is held by both national authorities and international forestry organizations. His career accomplishments serve as an implicit testament to his contributions and recognition in the field.

Research Skill🔬

Sándor Bordács possesses a comprehensive set of research skills rooted in over 30 years of experience in forestry, particularly in forest genetics and forest reproductive material (FRM). He is proficient in designing and managing long-term research projects related to genetic conservation, forest breeding, and the certification of planting materials. His background includes hands-on experience with molecular genetic techniques, gained through international fellowships in Austria. He is skilled in data analysis, regulatory research, and integrating scientific findings into policy and practice. Bordács has strong capabilities in drafting technical documentation, national regulations, and aligning forest genetic resource management with EU and OECD standards. Additionally, his experience in developing and using national databases on FRM and FGR enhances his technical expertise. His ability to collaborate across disciplines and cultures, combined with advanced communication and training skills, makes him adept at translating complex scientific concepts into practical applications for sustainable forest management and policy development.

Conclusion💡

Sándor Bordács is a highly credible and experienced forestry expert and academic, with proven leadership, training, and international collaboration credentials in the field of forest reproductive material and forest genetic resources. His nomination for a Best Researcher Award would be well-justified if the criteria emphasize applied science, regulatory impact, and long-term contributions to forestry genetics and ecosystem services.

However, if the award is strongly publication- or innovation-focused, it would be essential to include his scientific outputs and impact metrics to solidify his case.

Publications Top Noted✍

  • Title: Translating conservation genetics into management: Pan-European minimum requirements for dynamic conservation units of forest tree genetic diversity
    Authors: J Koskela, F Lefèvre, S Schueler, H Kraigher, DC Olrik, J Hubert, …
    Year: 2013
    Citations: 182

  • Title: Structure of the genetic diversity in black poplar (Populus nigra L.) populations across European river systems: consequences for conservation and restoration
    Authors: MJM Smulders, JE Cottrell, F Lefèvre, J Van der Schoot, P Arens, …
    Year: 2008
    Citations: 171

  • Title: Technical guidelines for genetic conservation and use: pedunculate and sessile oaks
    Authors: AA Ducousso, S Bordács
    Year: 2004
    Citations: 128

  • Title: Genetic considerations in ecosystem restoration using native tree species. State of the World’s Forest Genetic Resources–Thematic Study
    Authors: M Bozzano, R Jalonen, E Thomas, D Boshier, L Gallo, S Cavers, S Bordács, …
    Year: 2014
    Citations: 122

  • Title: Dynamic conservation of forest genetic resources in 33 European countries
    Authors: F Lefèvre, J Koskela, J Hubert, H Kraigher, R Longauer, DC Olrik, …
    Year: 2013
    Citations: 114

  • Title: Utilization and transfer of forest genetic resources: A global review
    Authors: J Koskela, B Vinceti, W Dvorak, D Bush, IK Dawson, J Loo, ED Kjaer, …
    Year: 2014
    Citations: 104

  • Title: Ex-situ conservation of Black poplar in Europe: genetic diversity in nine gene bank collections and their value for nature development
    Authors: V Storme, A Vanden Broeck, B Ivens, D Halfmaerten, J Van Slycken, …
    Year: 2004
    Citations: 97

  • Title: Chloroplast DNA variation of white oaks in northern Balkans and in the Carpathian Basin
    Authors: S Bordács, F Popescu, D Slade, UM Csaikl, I Lesur, A Borovics, P Kézdy, …
    Year: 2002
    Citations: 94

  • Title: Postglacial migration of Populus nigra L.: lessons learnt from chloroplast DNA
    Authors: JE Cottrell, V Krystufek, HE Tabbener, AD Milner, T Connolly, L Sing, …
    Year: 2005
    Citations: 91